(Q41005627)
Statements
Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing (English)
N J Meropol
G M Barresi
J Hitt
M Franklin
M A Caligiuri
1 August 1998